Prudential Financial’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
Other funds holding XLO
Prudential Financial's XLO Position: Q3 2026 in Review
Prudential Financial opened a new position in Xilio Therapeutics (XLO) in Q3 2026: 13,180 shares worth $119K. The stake represents ﹤0.01% of the portfolio and ranks #2395 among its holdings.
30 funds tracked by Wall St. Rank hold XLO as of Q3 2026.
- Prudential Financial held 13,180 shares of Xilio Therapeutics worth $119K as of Q3 2026.
- Xilio Therapeutics was a new Prudential Financial position in Q3 2026.
- Xilio Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q3 2026, its #2395 holding.
- 30 funds tracked by Wall St. Rank held Xilio Therapeutics as of Q3 2026.
Based on Prudential Financial's 13F filing for Q3 2026, filed 16 Nov 2026.